AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,000 | -33.3% | 563 | -6.5% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | +300.0% | 602 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $3,000 | -25.0% | 602 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $4,000 | 0.0% | 602 | -4.9% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | -20.0% | 633 | -5.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | +66.7% | 666 | +72.1% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | +50.0% | 387 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 387 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 387 | -14.8% | 0.00% | – |
| Q4 2017 | $2,000 | -33.3% | 454 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $3,000 | 0.0% | 454 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | +50.0% | 454 | +49.3% | 0.00% | – |
| Q1 2017 | $2,000 | – | 304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |